The Journal of Heart and Lung Transplantation
Volume 29, Issue 6 , Pages 687-691, June 2010

Optimization of axial-pump pressure sensitivity for a continuous-flow total artificial heart

  • O.H. Frazier, MD

      Affiliations

    • Department of Cardiovascular Surgery, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas
    • Corresponding Author InformationReprint requests: O.H. Frazier, MD, Department of Cardiovascular Surgery, Texas Heart Institute, P.O. Box 20345, MC 3-147, Houston, TX 77225-0345. Telephone: 832-355-3000. Fax: 832-355-6798
  • ,
  • Hassan A. Khalil, BS

      Affiliations

    • Department of Cardiovascular Surgery, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas
  • ,
  • Robert J. Benkowski, BS

      Affiliations

    • MicroMed Technology, Inc., Houston, Texas
  • ,
  • William E. Cohn, MD

      Affiliations

    • Department of Cardiovascular Surgery, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas

published online 05 February 2010.

Background

In this study, we describe the potential advantages of a continuous-flow total artificial heart (CFTAH) comprising two small, non-pulsatile pumps with optimized responsiveness to the pressure gradient.

Methods

We modified a MicroMed DeBakey axial-flow pump by increasing its inducer–impeller inlet angle, thereby increasing its pressure responsivity. We obtained the in vitro pressure gradient response and compared it with those of the clinically used, unmodified MicroMed DeBakey pump, Jarvik 2000 FlowMaker and HeartMate II.

Results

The modified pump showed an increased response to changes in the pressure gradient at pump flow rates of between 2 and 4 liters/min. The maximum pressure responsivity of the modified pump was 2.5 liters/min/mm Hg; the corresponding maximum responsivities of the Jarvik 2000, HeartMate II and MicroMed DeBakey ventricular assist devices (VADs) were 0.12, 0.09 and 0.38 liters/min/mm Hg, respectively.

Conclusions

Because of the inherent properties of non-pulsatile pumps, the CFTAH may potentially respond to changes in inflow and outflow pressures while maintaining physiologic flow rates sufficient for normal daily activity. In addition, the hemodynamic interplay between the two optimized pumps should allow a physiologic response to normal flow imbalances between the pulmonary and systemic circulations. Improved responsiveness to inflow pressure may further simplify and improve the CFTAH and affect its potential clinical use as a meaningful therapy for terminal heart failure.

Keywords: total artificial heart, blood pump–rotary, mechanical modeling, mechanical circulatory support, perfusion-nonpulsatile

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1053-2498(09)01538-1

doi:10.1016/j.healun.2009.12.017

The Journal of Heart and Lung Transplantation
Volume 29, Issue 6 , Pages 687-691, June 2010